Bayer to construct toluene diisocyanate plant in Germany
Bayer MaterialScience, a Bayer Group company, will build and operate a new facility at its Chempark Dormagen site, Germany, following approval from the Cologne district authority.
The new facility will manufacture toluene diisocyanate (TDI), which is used to produce flexible polyurethane foams to be used in high-quality foams for mattresses, chairs and car seats.
Bayer MaterialScience Executive Committee member responsible for the Polyurethanes Business Unit, Dr. Joachim Wolff, said the company is delighted that the approval process has been successfully completed and it can press ahead with the construction work as planned.
"This innovative high-tech process marks the start of safe and eco-friendly world-scale polyurethane production that makes the best possible use of energy and resources," Wolff added.
"Compared with a conventional plant with the same capacity, the new facility will reduce energy consumption by up to 60% and require as much as 80% less solvent. This will also give us a decisive competitive edge."
The plant, with an annual capacity of 300,000mt, forms part of a long-term investment strategy at Bayer MaterialScience to transform its Dormagen site into a world technology centre, to develop and produce polyurethanes.
In February 2012 the authorities gave the go-ahead for the provisional start of construction and since then, work at the construction site has been progressing.
Polyurethanes Business Unit production and technology head Dr. Steffen Kühling said: "If progress on site continues at this pace, there is nothing standing in the way of us completing and commissioning the plant midway through 2014."
The construction phase of the project is expected to provide between 500 and 1,500 additional jobs.